Technical Forum: Small-Molecule Synthesis - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Technical Forum: Small-Molecule Synthesis
Pharmaceutical Technology gains insight into approaches for producing aromatic amines.


Pharmaceutical Technology
Volume 34, Issue 9, pp. 48-50

References

1. R.N. Salvatore, C. H. Yoon, and K.W. Jung, Tetrahedron 57 (10) 7785–7811 (2001).

2. Y. Watanabe et al., Tetrahedron Lett. 22 (28), 2667–2670 (1981).

3. Y. Watanabe et al., J. Org. Chem. 49 (18), 3359–3363 (1984).

4. Y. Watanabe et al., J. Org. Chem. 61 (13), 4214–4218 (1996).

5. C. Jun et al., Chem. Commun. 13, 1405–1406 (1998).

6. R.A.T.M. Abbenhuis, J. Boersma, and G. van Koten, J. Org. Chem. 63 (13), 4282–4290 (1998).

7 T. Naota, H. Takaya, and S.I. Murahashi, Chem. Rev. 98 (7), 2599–2660 (1998).

8. R. Grigg et al. J. Chem. Soc. Chem. Commun. 12, 611–612 (1981).

9. G. Cami Kobeci, and J.M. Williams. J. Chem. Soc. Commun., 1072–1073 (2004).

10. K.I. Fujita and R. Yamaguchi, Synlett. 4, 560–571 (2005).

11. R. Yamaguchi et al., Org. Lett. 10 (2) 181–184 (2008).

12. D. Hollmann et al., Angew. Chem. Int. Ed. 46 (43), 8291–8294 (2007).

13. A. Tillack et al., Tetrahedron Lett. 47 (50), 8881–8885 (2006).

14. K. Fujita, Y. Enoki, and R. Yamaguchi, Tetrahedron 64 (8), 1943–1954 (2008).

15. M.H Hamid et al., J. Am. Chem. Soc. 131 (5), 1766–1774 (2009).

16. T.E. Müller and M. Beller, Chem. Rev. 98 (2), 675–704 (1998).

17. M. Beller et al., Chem. Eur. J. 5 (4), 1306–1319 (1999).

18. M. Nobis and B. Driessen-Hölscher, Angew. Chem., Int. Ed. 40 (21), 3983–3985 (2001).

19. M. Utsunomiya et al., J. Am. Chem. Soc. 125 (19), 5608–5609 (2003).

20. J.S. Ryu, G.Y. Li, and T.J.J. Marks, J. Am. Chem. Soc. 125 (19), 12584–12605 (2003).

21. A.M. Johns et al., J. Am. Chem. Soc. 128 (6) 1828–1839 (2006).

22. D. Chan et al., Tetrahedron Lett. 39 (19), 2933–2936 (1998).

23. D.A. Evans, J.L. Katz, and T.R. West, Tetrahedron Lett. 39 (19) 2937–2940 (1998).

24. P.Y.S. Lam, et al., Tetrahedron Lett. 39 (19) 2941–2944 (1998).

25. P.Y.S. Lam et al., Synlett. 5, 674–676 (2000).

26. J.P. Collman and M. Zhong, Org. Lett. 2 (9), 1233–1236 (2000).

27. J.C. Antilla and S.L. Buchwald, Org. Lett. 3 (13), 2077–2079 (2001).

28. P.Y.S. Lam et al., Tetrahedron Lett. 42 (20), 3415–3453 (2001).

29. C. Moessner and C. Bolm, Org. Lett. 7 (13), 2667–2669 (2005).

30. J.B. Lan et al., Synlett. 6, 1095–1097 (2004).

31. B. Sreedhar et al., Synthesis 5, 795–799 (2008).

32. T. Tsuritaniet et al., Org. Lett. 10 (8), 1653–1665 (2008).

33. S. Bérnard, L. Neuville, and J. Zhu, J. Org. Chem. 73 (16) 6441–6444 (2008).

34. Boronic Acids, D.G. Hall, Ed., (1st Edition, Wiley-VCH, Weinheim, Germany, 2005).

35. I. González et al., Org. Lett. 11 (8) 1677–1680 (2009).

36. M. Larrosa et al., Synlett., 14, 2101–2105, (2010).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here